Provantis to Increase Efficiencies and Further Improve Study Data Quality at Nanjing Research Facility
CONSHOHOCKEN, PA – Business Wire, June 4, 2019 - Instem, a leading provider of IT solutions to the global life sciences market, announced today that Jiangsu Provincial Institute of Materia Medica (JPIMM), has purchased the Provantis® preclinical SaaS solution suite to manage preclinical processes at its research facility in Nanjing.
May 8, 2018 - Instem to Showcase Preclinical Solutions and Outsourced Services at China’s Leading Toxicology Conference
April 19, 2018 - Instem To Showcase Leading Genetic Toxicology Solutions
March 22, 2018 - Leading Contract Research Organization Selects Cyto Study Manager to Optimize Genetic Toxicology Operations
March 7, 2018 - Instem Showcasing its Preclinical Solutions and Outsourced Services While Holding Educational Presentations Covering SEND and Target Safety Assessment